mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.006 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.009 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.44 |
0.01 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |